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Botulism: Food Safety
David Young, Foodborne Disease Epidemiologist
Botulism is a rare but serious illness caused by a potent 
neurotoxin produced by anaerobic, spore-forming 
Clostridium botulinum bacteria or other Clostridia strains. 
There are 5 categories of botulism: 
1. foodborne botulism; 
2. infant botulism resulting from an infant ingesting and 
becoming colonized with C. botulinum spores;
3. wound botulism resulting from wound contamination 
following a traumatic injuring and occurs more 
frequently among persons who inject drugs; 
4. adult intestinal toxemia a rare form of intestinal 
colonization in persons with a history of gastrointestinal 
surgery or illness like inflammatory bowel disease and
5. iatrogenic botulism resulting from an overdose of 
injected botulinum toxin for cosmetic or medical 
purposes. 
This article will focus on foodborne botulism.
Foodborne botulism occurs when a person ingests the 
botulinum toxin from contaminated food. The neurotoxin 
attacks the body’s nervous system which leads to illness 
within a few hours to days. Illness begins with involvement 
of the cranial nerves causing weakness or paralysis 
of the muscles that control the eyes, face, mouth and 
throat causing double or blurred vision, drooping eyelids 
slurred speech and difficulty swallowing. This weakness 
or paralysis may descend to the neck, arms, torso and 
legs. Botulism also can weaken or paralyze the muscles 
involved in breathing which can lead to difficulty breathing 
and even death.
The conditions in which C. botulinum 
spores can grow and make toxins 
in food include low-oxygen or 
anaerobic environment or low acid, 
sugar or salt environment conditions. 
Common sources of foodborne 
botulism are foods that have been 
improperly canned, preserved, or 
fermented during home processing. 
Though uncommon, store-bought 
foods also can be contaminated with 
botulinum toxin. 
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DHEC’s addition coincides with the Council of State and 
Territorial Epidemiologists (CSTE) Position Statement in 
June 2017, recommending that CRE become nationally-
notifiable for E. coli, Klebsiella, and Enterobacter species. 
After receiving and processing the clinical specimens 
from hospital or commercial laboratories, the DHEC 
Public Health Laboratory will continue shipping these 
samples to one of seven CDC Antibiotic Resistance 
Laboratory Network (ALRN) facilities for further testing 
and confirmation, as illustrated by the diagram below. 
The ALRN detects and tracks changes in resistance and 
helps public health departments identify and respond to 
outbreaks more quickly. 
In August, 2016, DHEC received Federal funding from 
CDC to establish a statewide Antimicrobial Resistance 
Collaborative. With partners from the University of South 
Carolina School of Medicine and College of Pharmacy, the 
Antimicrobial Stewardship Collaborative of South Carolina 
(ASC-SC) embarked on an ambitious journey to coordinate 
with healthcare providers across the state for a common 
goal: to reduce the threat of antimicrobial resistance in 
South Carolina. Multi-drug resistant organisms such as 
CRE and CRPA are a primary focus of ASC-SC’s activities 
across the state. 
U.S. Antibiotic Awareness Week took place November 
13-19, 2017. The campaign coincided with an international 
campaign from the World Health Organization, World 
Antibiotic Awareness Week. Please visit the following 
websites to learn what you can do to fight antibiotic 
resistance:
• https://www.cdc.gov/antibiotic-use/week/index.html
• http://www.who.int/campaigns/world-antibiotic-
awareness-week/2017/event/en/
Centers for Disease Control and Prevention. (2016). Retrieved from  
https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-
threats-2013-508.pdf
To prevent foodborne botulism safe home canning 
recommendations should be stringently followed, 
particularly for vegetables with a low acid content, which 
are the most common source of home canning related 
botulism. Store-bought and home-canned food containers 
should be inspected for leakage, bulging or swelling, 
cracks or other damage. Even containers that appear 
intact should be suspected to be contaminated if the 
container spurts liquid or foam when opened or the food 
inside is discolored, moldy, or smells bad.
Food that is suspected to be contaminated should be 
discarded. Instructions on the CDC web site at https://
www.cdc.gov/botulism/consumer.html will help prevent 
people and animals from accidentally coming into contact 
with food that may be contaminated.
Botulism is a reportable condition in 
South Carolina.
Suspected cases should be immediately reported to 
DHEC by phone. Botulinum toxin if administered early 
in the course of illness can prevent progression of 
illness and shorten its duration and can be requested 
from the CDC through DHEC if indicated.
This material was sourced from https://www.cdc.gov/botulism.
CRE and CRPA Reporting in SCION
Katie Waites, Healthcare Associated Infections Epidemiologist
Antimicrobial-resistant organisms continue to emerge 
as a growing public health concern. Isolates harboring 
a carbapenemase are considered a greater public 
health threat because they are potential reservoirs for 
transmission and amplification of a broad spectrum 
resistance mechanism. In 2013 the Centers for Disease 
Control and Prevention (CDC) published, “Antibiotic 
Resistant Threats in the United States” and named 
Carbapenem-resistant Enterobacteriaceae (CRE) an urgent 
threat to public health, noting that, “CRE have become 
resistant to nearly all the antibiotics we have today. Almost 
half of hospital patients who get bloodstream infections 
from CRE bacteria die from the infection.” (CDC, 2013). 
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) 
is noted as a serious threat.
In 2018, South Carolina will add CRE and CRPA to 
the List of Reportable Conditions. These conditions 
were only lab-reportable in 2017. Requiring provider 
reporting will provide epidemiological data not captured 
by laboratory reports. 
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Dengue Virus Infections
Dan Drociuk, Surveillance Epidemiologist
Dengue is a potentially fatal acute febrile illness caused 
by infection with any of four dengue viruses (DENV-1, -2, 
-3, and -4). Although ~75% of individuals infected with 
a DENV will be asymptomatic, ~5% of individuals that 
develop dengue will progress to severe dengue, an illness 
characterized by plasma leakage leading to hypovolemic 
shock, hemorrhage, and potentially death. The case-
fatality rate for individuals with severe dengue can be as 
high as 10% if untreated, or 0.1% with appropriate clinical 
management. 
DENVs are transmitted primarily through the bite of Aedes 
aegypti and Ae. albopictus mosquitoes. Because these 
mosquitoes are endemic throughout the tropics and sub-
tropics, an estimated 40% of the world’s population is at 
risk for DENV infection. These mosquitoes are also present 
in the United States. Ae. aegypti is present throughout 
southern Florida, southern Louisiana, parts of New Mexico 
and Arizona, prominently in urban centers in southern and 
central Texas, and have recently been detected in central 
California and southern Utah. Ae. albopictus is widely 
present throughout most of the southern United States and 
as far north as Illinois and New York. Both Ae. aegypti and 
Ae. albopictus have been found in mosquito traps in South 
Carolina. 
This photograph shows a mother applying mosquito repellent to her 
child’s skin in order to prevent mosquitos from biting. 
Centers for Disease Control and Prevention https://www.cdc.gov/
dengue/prevention/index.html
Symptoms of infection usually begin 4–7 days after a bite 
from an infected mosquito and typically last 3–10 days. In 
order for transmission to occur the mosquito must feed 
on a person during a 5-day period when large amounts 
of virus are in the blood; this period usually begins a little 
before the person becomes symptomatic. Asymptomatic 
people can still infect mosquitoes while they are viremic. 
The virus will require an additional 8–12 days incubation in 
the mosquito before it can then be transmitted to another 
human. The mosquito remains infected for the remainder 
of its life, which might be days or a few weeks. In rare 
cases dengue can be transmitted in organ transplants 
or blood transfusions from infected donors, and there 
is evidence of transmission from an infected pregnant 
mother to her fetus. 
Dengue epidemics require a coincidence of large numbers 
of vector mosquitoes, large numbers of people with no 
immunity to one of the four virus types and the opportunity 
for contact between the two. Although Aedes are common 
in the southern U. S., endemic in northern Mexico, and 
the U.S. population has no immunity, sustained dengue 
transmission does not occur in the continental U.S. 
primarily because contact between people and the vectors 
is too infrequent.
Nearly all dengue cases reported in the 48 continental 
states were acquired elsewhere by travelers or 
immigrants1,2. Imported cases rarely result in secondary 
transmission. Most dengue cases in U.S. citizens occur in 
those inhabitants of Puerto Rico, the U.S. Virgin Islands, 
Samoa and Guam, which are endemic for the virus. 
Outbreaks of dengue are infrequent; however several 
outbreaks have occurred in Florida in recent years3, which 
emphasize the need for continued vigilance by clinicians 
for possible cases in South Carolina. All individuals with 
imported dengue are advised to avoid local mosquito 
exposure during the time they could be viremic to prevent 
local transmission. 
There is no vaccine available against dengue, and there 
are no specific medications to treat a dengue infection. 
This makes prevention by avoiding mosquito exposure the 
most important step if you live in or travel to an endemic 
area. The best way to reduce mosquitoes is to eliminate 
the places where the mosquito lays eggs, like artificial 
containers that hold water in and around the home. 
Outdoors, clean water containers like pet and animal 
watering containers, flower planter dishes or cover water 
storage barrels. Look for standing water indoors such 
as in vases with fresh flowers and clean at least once a 
week. The adult mosquitoes like to bite inside as well as 
around homes, during the day and at night when the lights 
are on. To protect yourself, use repellent on your skin 
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while indoors or out. When possible, wear long sleeves 
and pants for additional protection. Also, make sure 
window and door screens are secure and without holes. If 
available, use air-conditioning. 
For more information, go to: www.cdc.gov/dengue.
Reference:
Dengue Epidemiology. Atlanta (GA): Centers for Disease Control and 
Prevention. https://www.cdc.gov/dengue/epidemiology/index.html. 
Updated July 9, 2014. Accessed June 23, 2017.
Footnotes:
1 Travel Associated Dengue Infections – United States, 2001- 2004 
2 Imported Dengue – United States, 1999 and 2000 
3  http://www.floridahealth.gov/diseases-and-conditions/dengue/
index.html
Update: Interim Guidance for 
Health Care Providers Caring for 
Pregnant Women with Possible 
Zika Virus Exposure
Leon Bullard, MD, MA, Acute Disease Epidemiology Medical Consultant
On July 24th, the Centers for Disease Control and 
Prevention, (CDC), released a revised protocol for Zika 
virus testing. This updated guidance was initiated by 
the CDC in response to accumulating evidence of 1) 
declining prevalence of Zika virus disease in the Americas 
and 2) emerging epidemiologic and laboratory evidence 
indicating prolonged Zika virus DNA (IgM antibodies) 
survival beyond 12 weeks post infection.
As the prevalence of Zika virus disease declines, the 
likelihood of false-positive test results increases. IgM 
test results for Zika antibodies cannot always reliably 
distinguish between an infection that occurred during the 
current pregnancy or one that occurred before the current 
pregnancy, particularly for women with possible Zika virus 
exposure before the current pregnancy. A specific Zika 
IgG test is not currently available in the US.
CDC’s key recommendations for healthcare professionals 
providing care for pregnant women include the following: 
1. All pregnant women in the United States and U.S. 
territories should be asked about possible Zika virus 
exposure before and during the current pregnancy, at 
every prenatal care visit.
2. Pregnant women with possible Zika virus exposure and 
symptoms of Zika virus disease should be tested to 
diagnose the cause of their symptoms. 
3. Asymptomatic pregnant women with ongoing possible 
Zika virus exposure should be offered Zika virus NAT 
testing three times during pregnancy.
4. Asymptomatic pregnant women who have recent 
possible Zika virus exposure (i.e., through travel 
or sexual exposure) but without ongoing possible 
exposure are not routinely recommended to have Zika 
virus testing.
5. Pregnant women who have recent possible Zika virus 
exposure and who have a fetus with prenatal ultrasound 
findings consistent with congenital Zika virus 
syndrome should receive Zika virus testing to assist in 
establishing the etiology of the birth defects.
6. The comprehensive approach to testing placental and 
fetal tissues has been updated.
7. Zika virus IgM testing as part of preconception 
counseling to establish baseline IgM results for non-
pregnant women with ongoing possible Zika virus 
exposure is not warranted.
The Zika virus disease testing protocol continues to 
evolve as new information is obtained. DHEC encourages 
healthcare providers for women of child-bearing age, 
and especially pregnant women, to be aware of the 
most current recommendations. The shared-decision 
making model, in which the patients and providers 
formulate a testing and treatment plan that incorporates 
the patients’ values and preferences with the clinicians’ 
clinical judgment, balanced risk assessment and potential 
outcomes, and the jurisdiction’s recommendations.
Legionnaires’ disease
Oluwole Babatunde, MBBS, MPH, Surveillance & Outbreaks 
Epidemiologist
In June 2017, the Centers for  
Disease Control and Prevention 
(CDC) published a Vital Signs 
report on Legionella associated 
with healthcare facilities. 
Legionnaires’ disease (LD) is a 
serious, and often deadly, cause 
of pneumonia. Individuals become infected by breathing in 
water droplets containing Legionella bacteria. People can 
also become infected if contaminated water accidentally 
enters the lungs while drinking. Hospitalized individuals 
and those in long-term care facilities may be at increased 
risk of complications from LD due to underlying medical 
conditions. Legionella should be considered in the 
differential diagnosis of anyone with atypical pneumonia or 
unexplained febrile illness, especially among patients aged 
65 years and above, patients who have a history of 
smoking, pre–existing Chronic Obstructive Pulmonary 
Disease (COPD), or diabetes and/or a compromised 
immune system. Diagnostic tests for Legionella include the 
urine antigen test or isolation of the organism from 
respiratory secretions, lung tissue, pleural fluid, or other 
normally sterile fluid. 
Legionellosis 
is a reportable 
condition in 
South Carolina. 
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LEGIONNAIRES’ DISEASE CASES IN  
SOUTH CAROLINA, 2012–2016*
2012 2013 2014 2015 2016 Total
Number of Cases 26 22 44 63 62 217
Mean of 43 cases per year
* Case counts do not include visitors reported in their state of residence 
who may have acquired disease in South Carolina.
PERCENT OF LEGIONNAIRES’ DISEASE  
CASES ASSOCIATED WITH A HEALTH CARE 
FACILITY - 2016
Definitely 
associated
Possibly 
associated
Not 
associated
Unknown
5% 14% 37% 44%
Legionella grows best in buildings with large water 
systems that are not managed effectively. Community-
acquired LD is associated with showers, faucets, cooling 
towers (air-conditioning units for large buildings), hot tubs 
that are not drained after each use, decorative fountains, 
hot water tanks, and large plumbing systems. Effective 
water management programs reduce the risk of Legionella 
growing and spreading in building water systems and 
can help prevent LD. To prevent LD, health care facilities 
should be aware of and adopt the new CDC guidelines 
published in June 2016. These guidelines  
recommend that a water management program  
be implemented for health care facilities where  
patients stay overnight or that house or treat  
people who have chronic and acute medical  
problems or weakened immune systems. 
A Legionella water management program routinely  
consists of:
1. Establishing a water management program team.
2. Describing the building water systems using words and 
diagrams.
3. Identifying areas where Legionella could grow and 
spread.
4. Deciding where control measures should be applied 
and how to monitor them.
5. Establishing ways to intervene when control limits are 
not met.
6. Making sure the program is running as designed and is 
effective.
7. Documenting and communicating all the activities.
CDC recommends a full investigation of any single LD 
case who spent their entire incubation period (2-10 days) in 
the same facility. A full investigation is also recommended 
for two or more cases who spent a portion of their 
incubation period in the same facility. 
Additional information available at:
https://www.cdc.gov/legionella/health-depts/inv-tools-single. 
https://www.cdc.gov/vitalsigns/legionella/. 
https://wwwn.cdc.gov/nndss/conditions/legionellosis/case-
definition/2005/.
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Pertussis Testing
Steven Battle, DO, MPH, Acute Disease Epidemiology Medical 
Consultant
Pertussis, more commonly known as whooping cough, 
was a common childhood disease and a major cause of 
child and infant mortality in the United States during its 
pre-vaccine era. Pertussis is a contagious respiratory 
disease caused by the bacterium Bordetella pertussis. The 
illness is characterized by a prolonged paroxysmal cough 
(multiple, rapid coughs), which is often accompanied by 
an inspiratory whoop. Disease presentation can vary with 
age and history of previous exposure or vaccination. Early 
diagnosis and treatment of pertussis might limit its spread 
to other susceptible people. Pertussis testing should be 
considered in individuals with prolonged paroxysmal 
coughing. 
Persons with pertussis are infectious from the beginning 
of the catarrhal stage (runny nose, sneezing, low-grade 
fever, symptoms of the common cold) through the third 
week after the onset of paroxysms or until five days after 
the start of effective antimicrobial treatment. Treatment 
should not be delayed pending the results of testing. 
Asymptomatic contacts of confirmed cases should not be 
tested and testing of contacts should not be used for post-
exposure prophylaxis decisions. 
Isolation of B. pertussis by bacterial culture remains the 
gold standard for diagnosing pertussis according to 
the Centers for Disease Control and Prevention (CDC). 
However, the fastidious growth requirements make B. 
pertussis difficult to isolate. Serologic testing is not 
recommended to confirm the diagnosis of pertussis 
because antibody response can be non-specific or could 
reflect previous disease. Commercially, there are many 
different serologic tests used in the United States with 
unproven or unknown clinical accuracy. Serologic testing 
could be useful for adults and adolescents who present 
late in the course of their illness, when both culture and 
Polymerase Chain Reaction (PCR) are likely to be negative. 
PCR testing is an important tool for timely diagnosis of 
pertussis and is increasingly available to clinicians. PCR 
detects DNA sequences of the B. pertussis bacterium, 
and unlike culture, does not require viable (live) bacteria 
present in the specimen. However, the high sensitivity of 
PCR means false positive results may be obtained. CDC 
recommends the following best practices to reduce the 
risk of obtaining inaccurate results:
1. Only test patients with signs and symptoms consistent 
with pertussis. 
2. Perform PCR testing for pertussis during the optimal 
time frame. PCR testing is most reliable within the 
first three weeks after onset of cough and before the 
initiation of antibiotic therapy.
3. Optimize specimen collection
• Obtain specimens for PCR testing by aspiration or 
swabbing the posterior nasopharynx. 
• Use thin, flexible, nasopharyngeal swabs with 
polyester, rayon, or nylon tips and aluminum or 
plastic shafts. 
• Throat swabs and anterior nasal swabs are not 
acceptable specimens. 
• Nasopharyngeal and aspirate specimen collection 
procedures can be found at https://www.cdc.gov/
pertussis/clinical/diagnostic-testing/specimen-
collection.html.
4. Avoid contamination of the clinical specimen by general 
adherence to basic infection control measures to 
prevent contamination of specimens.
5. Appropriately interpret testing results.
Clinical case definition: In absence of a more likely 
diagnosis a cough illness lasting > 2 weeks with one of the 
following symptoms:
• Paroxysms of coughing, OR
• Inspiratory “whoop”, OR
• Posttussive vomiting, OR
• Apnea (with or without cyanosis) (For infants aged <1 
year only)
PCR is an important tool for diagnosis of pertussis 
especially in the setting of the current resurgence of 
pertussis disease. PCR can provide timely results with 
improved sensitivity over culture. Careful specimen 
collection and transport and a general understanding 
of the PCR assays performed will better ensure that 
clinicians obtain diagnostic test results that reliably 
inform patient diagnosis. Cases meeting the clinical case 
definition that are serologically positive, but not culture 
or PCR positive should be reported as probable cases to 
your local health department. South Carolina health care 
providers are required to report pertussis cases to the 
county health department where the patient resides 
within 24 hours by phone. For more information about 
reporting conditions in SC, go to: http://www.scdhec.gov/
Library/CR-009025.pdf.
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Health care providers are encouraged to contact your 
county health department with questions about testing for 
pertussis. 
For more information, go to https://www.cdc.gov/
pertussis/clinical/index.html.
References:
Best Practices for Healthcare Professionals on the Use of Polymerase 
Chain Reaction (PCR) for Diagnosing Pertussis. Atlanta (GA): Centers 
for Disease Control and Prevention. https://www.cdc.gov/pertussis/
clinical/diagnostic-testing/diagnosis-pcr-bestpractices.html
Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 
10: Pertussis. Atlanta (GA): Centers for Disease Control and Prevention. 
https://www.cdc.gov/vaccines/pubs/surv-manual/chpt10-pertussis.
html
Updates to the List of Reportable 
Conditions for 2018
South Carolina Law 44-29-10 and Regulation 61-20 require 
reporting of conditions on the Official List of Reportable 
Conditions in the manner prescribed by DHEC. Changes in 
reporting criteria for 2018 are listed below.
• Footnote 12: Specimen submission of the first isolate of 
the month to the Public Health Laboratory is required 
for Carbapenem-resistant Pseudomonas aeruginosa.
Updates to Reportable Conditions
• Carbapenem-resistant Enterobacteriaceae (CRE) is 
now notifiable.
• Carbapenem-resistant Pseudomonas aeruginosa 
(CRPA) is now notifiable.  
• “Staphylococus aureus, vancomycin-resistant or 
intermediate” with a VA > 6 MIC (VRSA/VISA).
• “Bureau of Laboratories (BOL)” name has changed to 
Public Health Laboratory (PHL).
• Footnote 6: Rabies PCP guidance name changed to 
Rabies exposure prophylaxis
• Footnote 8: A pure, low passage isolate submitted on 
a non inhibitory, non-selective agar plate or slant is 
preferred.
• Footnote 10: A suspect case of TB is a person whom 
a health care provider suspects TB based on signs, 
symptoms, and/or laboratory evidence of TB.
Reporting reminders
1. What to report:
For all suspected and confirmed cases, report the 
following:
• Patient’s name
• Patient’s complete address, phone, county, date of 
birth, race, sex, last five digits of social security number
• Physician’s name and phone number
• Name, institution, and phone number of person 
reporting 
• Disease or condition 
• Date of diagnosis 
• Symptoms
• Date of onset of symptoms
• Lab results, specimen site, collection date
• If female, pregnancy status 
• Patient status: In childcare, food-handler, healthcare 
worker, childcare worker, nursing home, prisoner/
detainee, travel in last 4 weeks
2. How to report
This section’s layout was updated to clarify where specific 
conditions should be reported. 
HIV, AIDS and STDs (excluding Hepatitis): 
Do not fax HIV, AIDs or STD results to DHEC 
Call 1-800-277-0873; 
Submit electronically via DHEC’s web-based reporting 
system; or 
Mail to: 
Division of Surveillance & Technical Support  
Mills/Jarrett Complex 
Box 101106, Columbia, SC 29211
LEAD: 
Mail to: 
Bureau of Health Improvement & Equity, Lead Surveillance 
c/o Brian Humphries 
Sims-Aycock Building, 2600 Bull Street, 
Columbia, SC 29201 
Fax: 803-898-3236 
Call 803-898-3641 to establish electronic reporting
This section’s layout was updated to reflect the changes 
in the telephone numbers for the Lowcountry. TB must be 
reported to the public health office in the region in which 
the patient resides.
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Where to Report Tuberculosis
Lowcountry Midlands Pee Dee Upstate
Berkeley, Charleston 
Office: (843) 719-4612 
Fax: (843) 719-4778
Chester, Kershaw, Lancaster, 
Newberry, York 
Office: (803) 909-7357 
Fax: (803) 327-4391
Dillon, Georgetown, Horry, 
Marion 
Office: (843) 915-8798 
Fax: (843) 915-6504
Cherokee, Spartanburg, Union 
Office: 864-596-2227 ext. 108 
Fax: 864-596-3340
Allendale, Bamberg, Beaufort, 
Calhoun, Colleton, Hampton, 
Jasper, Orangeburg 
Office: 843-549-1516 ext. 222 
Fax: 843-549-6845
Aiken, Barnwell, Edgefield, 
Fairfield, Lexington, Richland, 
Saluda 
Office: (803) 576-2870 
Fax: (803) 576-2880 
Chesterfield, Clarendon, 
Darlington, Florence, Lee, 
Marlboro, Sumter, Williamsburg 
Office: (843) 673-6693 
Fax: (843) 661-4844
Abbeville, Anderson, Greenwood, 
Laurens, McCormick, Oconee, 
Pickens 
Office: (864) 227-5955 
Fax: (864) 942-3690
Greenville 
Office: (864) 372-3198 
Fax:(864) 282-4294
Nights/Weekends/Holidays: (803) 898-0558     Fax: (803) 898-0685
This section’s layout was updated to reflect the changes in the telephone numbers for the Lowcountry. All conditions other 
than HIV, AIDS, STDs, Lead and TB must be reported to the public health office in the region in which the patient resides. 
Immediately and urgently reportable conditions must be reported by telephone. Conditions which are routinely reportable 
must be reported via mail, fax or submitted electronically via DHEC’s web-based reporting system.
Immediate and Urgent Reporting (TELEPHONE) 3-Day Reporting 
(MAIL or FAX)
Lowcountry Midlands Pee Dee Upstate Lowcountry 
4050 Bridge View Drive, 
Suite 600 
N. Charleston, SC 29405 
Fax: (843) 953-0051
Berkeley, Charleston, 
Dorchester  
Phone: (843) 953-0043
Kershaw, Lexington, 
Newberry, Richland  
Phone: (803) 576-2749
Chesterfield, Darlington, 
Dillon, Florence, Marion, 
Marlboro  
Phone: (843) 661-4830
Anderson, Oconee  
Phone: (864) 260-5581
Beaufort, Colleton, 
Hampton, Jasper  
Phone: (843) 549-1516  
ext. 218
Chester, Fairfield, 
Lancaster, York  
Phone: (803) 286-9948
Clarendon, Lee, Sumter  
Phone: (803) 773-5511
Abbeville, Greenwood, 
McCormick 
Phone: (864) 260-5581
Midlands 
2000 Hampton Street 
Columbia, SC 29204 
Fax: (803) 576-2993
Allendale, Bamberg, 
Calhoun, Orangeburg  
Phone: (803) 268-5833
Aiken, Barnwell, 
Edgefield, Saluda  
Phone: (803) 642-1618
Georgetown, Horry, 
Williamsburg  
Phone: (843) 915-8804
Cherokee, Greenville, 
Laurens, Pickens, 
Spartanburg, Union  
Phone: (864) 372-3133
Pee Dee 
145 E. Cheves Street 
Florence, SC 29506 
Fax: (843) 661-4859
Nights/Weekends  
Phone: (843) 441-1091
Nights/Weekends  
Phone: (888) 801-1046
Nights/Weekends  
Phone: (843) 915-8845 
Nights/Weekends 
Phone: (866) 298-4442
Upstate 
200 University Ridge 
Greenville, SC 29602 
Fax: (864) 282-4373
Links for Disease Reporting Information
Reportable Diseases Page on DHEC website 
www.scdhec.gov/Health/FHPF/ReportDiseasesAdverseEvents/ReportableConditionsInSC
PDF List of Reportable Conditions 
www.scdhec.gov/library/CR-009025.pdf
SC DHEC Disease Reporting Form 
www.scdhec.gov/library/D-1129.pdf
Questions?
For questions about Disease Reporting or to discuss electronic disease reporting via DHEC’s electronic disease 
surveillance reporting system, call the DHEC Bureau of Disease Control in Columbia: 803-898-0861 (M-F 8:30 AM to 5 PM). 
To learn about DHEC’s web-based reporting system, call 1-800-917-2093 (M-F 8:30 AM to 5 PM).
Epi Notes is published by the South Carolina Department of Health and Environmental Control 
Bureau of Communicable Disease Prevention and Control. 
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